# Efficacy and Safety Study of Fluvastatin and Ezetimibe Combined Versus Fluvastatin Alone

> **NCT00171288** · PHASE3 · COMPLETED · sponsor: **Novartis** · enrollment: 83 (actual)

## Conditions studied

- Dyslipidemia

## Interventions

- **DRUG:** fluvastatin, ezetimibe

## Key facts

- **NCT ID:** NCT00171288
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-08
- **Primary completion:** 2005-08
- **Final completion:** 2005-08
- **Target enrollment:** 83 (ACTUAL)
- **Last updated:** 2011-11-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00171288

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00171288, "Efficacy and Safety Study of Fluvastatin and Ezetimibe Combined Versus Fluvastatin Alone". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00171288. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*